Comparative Clinical Evaluation of Two Techniques in the Arthroscopic Treatment of Partial Articular Rotator Cuff Tears after Six Years of Follow-up

两种关节镜治疗部分肩袖撕裂技术的比较临床评价及六年随访结果

阅读:4

Abstract

Objective  To clinically evaluate the medium-term results of the arthroscopic treatment of partial-thickness rotator cuff tears (PTRCT) using the transtendon repair (TTR) technique and the tear completion repair (TCR) technique through the modified University of California, Los Angeles (UCLA) Shoulder Rating Scale, the Constant-Murley score, and force analysis. Methods  The present was a retrospective reevaluation study of cases operated on arthroscopically for PTRCT after a minimum follow-up of 6 years. There were 34 patients, 18 of whom underwent TTR and 16, TCR. We compared the current UCLA and Constant-Murley scores, the mean strength between the techniques, and the UCLA score currently and 2 years after surgery for the same group, as published in a previous study, to assess whether or not the results changed throughout time. Results  There was no statistical difference regarding the scores. The current UCLA scores were of 33.8 for the TTR and of 32.9 for the TCR ( p  = 0.113), and the current Constant-Murley scores were of 91.9 and 86.8 respectively ( p  = 0.075). For the TTR, the previous UCLA score was (2 years postoperatively) of 32.4 and the current score was of 33.8 ( p  = 0.374); for the TCR, the score after 2 years was of 32.4, and the current score was of 32.9 ( p  = 0.859). In the TTR, the mean strength was statistically higher on the dominant side (11 kg) than on the non-dominant side (7.80 kg) ( p  = 0.023) and those of the TCR (8.25 kg) ( p = 0.042). Conclusion  There was no statistical difference in the medium term when comparing the UCLA and Constant-Murley scores concerning the technique used (TTR or TCR), nor was there any change in UCLA scores between 2 and 6 years postoperatively. Among the patients submitted to TTR, the mean strength was statistically higher on the dominant side than on the non-dominant side, and higher than that of the patients submitted to TCR.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。